LXK : Summary for Lexmark International, Inc. Com - Yahoo Finance

U.S. Markets open in 3 hrs 38 mins

Lexmark International, Inc. (LXK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.490.00 (0.00%)
At close: 4:00 PM EST
People also watch:
JBLLLTCMDPKLACMAS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close40.49
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume1,002,098
Market Cap2.55B
BetaN/A
PE Ratio (TTM)-37.46
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Lexmark International Inc (LXK) A Good Stock To Buy Right Now?
    Insider Monkey2 days ago

    Is Lexmark International Inc (LXK) A Good Stock To Buy Right Now?

    Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players […]

  • The Wall Street Journal4 days ago

    [$$] BUSINESS Watch

    The Supreme Court said Friday it would review Lexmark International Inc.’s power to prevent third-party companies from refilling and reselling patented toner cartridges initially sold by the Lexington, ...

  • Reuters5 days ago

    U.S. top court to hear printer cartridge dispute on patent rights

    The U.S. Supreme Court on Friday agreed to hear an appeal by printer cartridge reseller Impression Products Inc of a lower court ruling finding it liable for infringing patent rights of Lexmark International Inc when it imported Lexmark's toner products back to the United States after they were sold abroad. If upheld by the justices, the February ruling by the U.S. Court of Appeals for the Federal Circuit favoring Kentucky-based Lexmark would reinforce U.S. patent owners' ability to control the use of their products even after they are sold.